Table of Contents Table of Contents
Previous Page  94 / 916 Next Page
Show Menu
Previous Page 94 / 916 Next Page
Page Background


25th European Congress of Psychiatry / European Psychiatry 41S (2017) S69–S105

also have evidence-based studies that depression for example is an

independent risk factor of heart infarct onset. On the other hand,

we observe the somatization of clinical picture of mental disorders,

the increase of atypical forms manifesting through pain or other

somatic syndromes that leads to the increase of mental illnesses in

the primary care. The research of common pathways of mental and

somatic pathology should be the subject of further interdisciplinary

research programs. The other issue is the patient’s compliance that

plays in important role in the success of every kind of treatment.

Personality traits and status of mental health can influence ones

attitude to illness as well as motivation to therapy. We cannot

assess the population state of health without taking into consid-

eration the evaluation of mental status as well as such definitions

like subjective well being, life quality and stigmatization.

Disclosure of interest

The authors have not supplied their decla-

ration of competing interest.

Oral communications: Epidemiology and social

psychiatry; migration and mental health of

immigrants; forensic psychiatry; suicidology and

suicide prevention; prevention of mental

disorders and promotion of mental health


Personality disorders and perinatal

psychiatry: Food for thoughts from

perinatal psychiatric department


E. Di Giacomo

1 ,

, F. Colmegna


, M. Clerici



PhD program in Neuroscience–Doctorate School of the University of

Milano–Bicocca, Psychiatric Department–S. Gerardo Health Care

Trust–Italy, Milan, Italy


S. Gerardo Health Care Trust, Psychiatric Department, Monza, Italy


University of Milano Bicocca, School of Medicine and Surgery,

Milan, Italy

Corresponding author.


Pregnancy and postpartum are sensitive unique

moments in women’s life. Perinatal psychiatry is focused on

depression and psychosis, but personality issues is often neglected

as well as risk factors for personality disorders instead of being

considered causative of onset or recrudescence of psychiatric

symptoms in perinatal.


In total, 129 women were referred to perinatal psychi-

atric department during their pregnancy or postpartum in the last

three years. They were administered SCID II, Childhood Trauma

Questionnaire (CTQ), Beck Depression and Anxiety Inventories (BDI

and BAI), Edinburgh Postnatal Depression Scale (EPDS) and World

Health Organization Quality of Life (WHOQOL). Their interaction

with babies wasmonitored at birth and during followup. Children’s

behavioral development is under evaluation through structured



BDI and BAI scored moderate or severe in 31 and 27%

of women, EPDS was significant in 36%, while SCID II highlighted

24% of borderline, 17% narcissistic, 4% schizoid, 4% paranoid and 9%

obsessive/compulsive PD. Nineteen of themsuffered physical abuse

during childhood, 26 sexual abuse, 89 emotional neglect and only

15 out of 129 were negative to any kind of abuse during childhood.


Personality disorders appears to influence maternal

adjustment to pregnancy and motherhood. Abuses suffered during

childhood confirm their role as potential risk factor in personality

issues which clearly express their effect in adaptation to change in

personal role and in emphatic interactions.

Disclosure of interest

The authors have not supplied their decla-

ration of competing interest.


What do patients want? Correlates of

patient satisfaction and treatment


R. Gearing

, A. W


University of Houston, GCSW, Houston, USA

Corresponding author.


Motivation and ability to engage with treatment

may deteriorate or falter if a patient is not satisfied with their

protocols or provider. Improving patient satisfaction may more

effectively strengthen treatment engagement.


1) Determining what patients want from their

provider relationship; and 2) identifying means for a provider to

effectively assess and evaluate patient satisfaction in relation to

treatment engagement.


A systematic review of published meta-analyses, sys-

tematic reviews, and literature reviews between 1996 and

2016 was conducted across three databases (Medline, PsycINFO,

CINAHL). Using variations of the search terms patient; satisfaction;

medication, medical and psychiatric treatment; and engage-

ment/adherence, a total of 1667 articles were identified. After

removing duplications, 1582 articles were independently screened

for eligibility (e.g. conceptual focus, methodological limitations)

by two research assistants, resulting in the final inclusion of 50

meta-analysis, systematic review, or literature review articles that

focused on predictors or barriers to patient satisfaction and/or pre-

dictors or barriers affecting engagement/adherence.


Barriers and predictors of patient satisfaction centered

on two fundamental domains:

– relationship with Provider (sub-factors: multicultural compe-

tence, shared decision making, communication skills, continuity of

care, empathy) and;

– outcomes (sub-factors: therapeutic outcome, patient expecta-


Eight treatment engagement/adherence barrier and predictor

domains were identified, specifically treatment regimens; ill-

ness beliefs, emotional/cognitive factors; financial and logistic;

social support; symptom/illness characteristics; demographics and

patient-provider relationship.


Key findings highlight actions psychiatrists and

other clinical providers may consider in addressing barriers and

highlighting promoters to improve patient satisfaction and overall

engagement and adherence.

Disclosure of interest

The authors have not supplied their decla-

ration of competing interest.


The efficacy of lurasidone on PANSS

subscales in adolescent patients with

schizophrenia: Results from a 6-week,

double-blind, placebo-controlled,

multicenter study

C. Correll

1 , 2

, R. Goldman

3 ,

, J. Cucchiaro


, L. Deng


, A. Loebel



Hofstra Northwell School of Medicine, Psychiatry and Molecular

Medicine, Hempstead, NY, USA


The Zucker Hillside Hospital, Department of Psychiatry, Glen Oaks,



Sunovion Pharmaceuticals Inc., Medical Affairs, Fort Lee, NJ, USA


Sunovion Pharmaceuticals Inc., Clinical Operations, Fort Lee, NJ, USA


Sunovion Pharmaceuticals Inc., Biostatistics, Fort Lee, NJ, USA